| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.041 | 0.1 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.1 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.1 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.2 |